Optimal Timing for Minor Amputation After Revascularization in Ischemic Diabetic Foot: A Case-Based Review

Peripheral arterial disease (PAD) affects up to 50% of patients with diabetes-related foot ulcers. This condition is associated with an increased risk of delayed or nonhealing wounds, gangrene, and amputation, as well as high rates of cardiovascular disease and mortality.^1,2

Multiple factors can contribute to delayed or failed healing of diabetic foot ulcers (DFUs), including infection, wound size and depth, excessive pressure at the lesion site, and suboptimal local wound care. However, PAD remains the most important determinant of outcome.²

The available literature shows that early revascularization within the first 8 weeks of ulcer onset is associated with a greater likelihood of healing and a reduced risk of limb loss in DFUs.^3,4 Among people with diabetes, the lifetime risk of developing a DFU is 19% to 34%; of those who develop a DFU, 4.2% to 9.6% require amputation.

Several studies have aimed to determine the most effective type of revascularization, comparing bypass surgery with endovascular procedures. Results indicate that when a suitable venous conduit for bypass is available, this technique yields better outcomes in terms of limb salvage and mortality than endovascular revascularization.⁵

There is currently no strong guideline recommendation regarding the optimal timing of minor amputation after revascularization.

The purpose of this article is to review the current literature using a clinical case to determine the optimal timing for performing amputation in patients with DFUs and established PAD.

A narrative literature review was performed using PubMed and SciELO. Search terms included “minor amputation”, “revascularization”, “diabetic foot”, “critical limb ischemia”, and “chronic limb-threatening ischemia”, used individually and in combination. Particular attention was given to publications evaluating the timing of minor amputation after lower-extremity revascularization and to studies assessing the evolution of tissue perfusion after revascularization, including changes in microcirculatory parameters and tissue oxygenation.

We present the case of a 62-year-old man with a history of former tobacco use, arterial hypertension, end-stage kidney disease requiring hemodialysis, type 2 diabetes mellitus with good metabolic control, and dyslipidemia.

His vascular history was notable for a right fifth-toe transmetatarsal amputation. Because of poor wound healing, 1 month later he underwent an anterior femorotibial bypass using a reverse great saphenous vein graft. One year later, stenosis of the proximal and distal anastomoses required angioplasty, and amputation of the distal phalanx of the first toe and proximal phalanx of the second toe was performed.

Three months later the patient presented to the emergency department with right foot pain and was diagnosed with thrombosis of the anterior femorotibial bypass graft.  He reported progressive worsening of intermittent claudication, now occurring at very short walking distances, as well as rest pain.

Physical examination

Lower limbs:

• Right leg: Grade 3 femoral pulse. No palpable bypass pulse. Necrosis at the first toe amputation site, with an erythematous-cyanotic area over the first metatarsal head (Figure 1).
• Right leg ankle-brachial index: 0.38 with low amplitude monophasic waveform in dorsalis pedis and posterior tibial arteries. Ankle collapse at 50 mm Hg.

The patient was diagnosed with a diabetic foot ulcer: TEXAS IC, PEDIS 1-2, W1I3fI0 on the right lower limb and Rutherford Category 5 on the right lower limb.

Summary of evolution

The patient was initially treated with systemic anticoagulation and analgesic therapy during hospitalization, which resulted in improved pain control. His lesions worsened with increased inflammation and intensified pain (TEXAS IIID, PEDIS 3, W1I3fI2).

Endovascular angioplasty of the superficial femoral, popliteal, and anterior tibial arteries was performed via a contralateral approach. A transmetatarsal debridement/amputation of the first and second toes was performed because of deep infection. Cultures grew Staphylococcus aureus and Stenotrophomonas maltophilia (Figure 2).

Post-revascularization, the wound bed showed improved viability and decreased inflammation, allowing for proximal reamputation of the first and second toes with near-complete closure 12 days later (Figure 3).

The patient was discharged 16 days after revascularization, continuing oral antibiotics for 1 additional week after 4 weeks of intravenous antibiotics. At follow-up 25 days after the final amputation, the patient reported intermediate-distance claudication, no rest pain, and excellent healing with no dehiscence. Antibiotics had been discontinued (Figure 4).

Chronic limb-threatening ischemia (CLTI) associated with diabetic foot infection represents one of the most challenging scenarios in vascular surgery. Successful limb salvage requires adequate control of infection, restoration of arterial perfusion, and appropriate surgical management of nonviable tissue. While current guidelines emphasize the importance of revascularization in patients with ischemic tissue loss, the optimal timing of minor amputation following revascularization remains poorly defined.

Early restoration of arterial inflow has consistently been associated with improved limb salvage outcomes. Sheahan et al demonstrated that delays in revascularization were associated with significantly higher limb loss rates in patients undergoing minor amputations. In their cohort of 670 patients, earlier revascularization was associated with a 76% reduction in nonhealing amputations.⁶ These findings highlight the importance of restoring blood flow as a first step in the management of ischemic diabetic foot lesions.

Two current international guidelines recommend revascularization before definitive amputation in patients with CLTI when infection is not immediately limb- or life-threatening.^7,8 However, neither guideline provides clear recommendations regarding the optimal interval between successful revascularization and subsequent surgical procedures such as minor amputations or definitive debridement.

The limited available evidence suggests that the timing of surgical intervention after revascularization may influence healing outcomes. Tanda et al reported an increased risk of reamputation when minor amputations were performed within 14 days after revascularization.⁹ However, the study excluded patients with infected diabetic foot lesions, limiting the applicability of these findings in routine clinical practice, where infection is frequently present. Earlier work by Albrektsen et al suggested that delaying debridement for several days following revascularization may improve wound healing even in the presence of necrotic tissue.¹⁰

One possible explanation for these observations is the progressive improvement in tissue perfusion that occurs after restoration of arterial inflow. Although macrovascular flow may be restored immediately after revascularization, microcirculatory perfusion and tissue oxygenation often improve gradually. Several studies have demonstrated that parameters such as transcutaneous partial pressure of oxygen (TcPO₂) increase over time after successful revascularization. TcPO₂ values above 25 to 30 mm Hg are generally associated with improved wound healing, while higher thresholds around 40 mm Hg may provide even greater predictive value.¹¹

Evidence from endovascular revascularization studies indicates that recovery of tissue oxygenation is a progressive process that may extend over several weeks after restoration of arterial patency. During angioplasty, TcPO₂ may decrease transiently and often remains close to baseline values at the end of the procedure. Only modest increases are generally observed within the first 24 to 48 hours, whereas the most substantial improvements occur during the following weeks.^12,13 These observations are clinically relevant because they suggest that the microcirculatory response to revascularization lags behind the immediate technical success of the procedure.

The full benefit of revascularization at the tissue level may not be apparent in the early postoperative period, supporting the hypothesis that delaying definitive minor amputation could allow time for further improvement in tissue perfusion and wound-healing potential. Other methods may help assess the adequacy of tissue perfusion after revascularization:

Skin perfusion pressure (SPP) has been associated with wound healing, with values above 40 mm Hg generally considered favorable, and some studies suggest that early postoperative SPP measurements may predict healing outcomes more accurately than TcPO₂.

Toe pressure and the toe-brachial index have also demonstrated prognostic value following revascularization; however, their applicability may be limited in patients with previous toe amputations, extensive forefoot tissue loss, or advanced arterial calcification.^14,15

Pedal acceleration time has emerged as a useful noninvasive marker of arterial inflow and technical success after revascularization. It also has been associated with limb salvage outcomes.¹⁶

Unlike most hemodynamic tests, both TcPO₂ and SPP provide information regarding tissue-level perfusion and microcirculatory recovery, which may be particularly relevant when determining whether sufficient perfusion has been achieved where minor amputation healing must occur.

The progressive improvement in TcPO₂ observed after successful endovascular revascularization suggests that restoration of tissue perfusion is not an immediate event but rather a dynamic process that may continue over several weeks. This observation may be especially relevant when considering angiosome- and woundosome-guided revascularization strategies. Several studies have shown that direct revascularization of the artery supplying the wound area is associated with faster wound healing, improved limb salvage, and lower amputation rates compared with indirect revascularization.¹⁷ More recent evidence suggests that indirect revascularization through well-developed collateral circulation may achieve outcomes comparable to direct revascularization, whereas indirect revascularization without effective collateral supply is consistently associated with poorer results.¹⁸

From a clinical perspective, these findings suggest that the optimal interval between revascularization and minor amputation may not be the same for all patients. Direct reperfusion of the wound area could potentially allow earlier recovery of tissue perfusion, whereas patients dependent on collateral-mediated flow may require more time to achieve similar physiological conditions. Doyle et al suggest that delaying minor amputations for 15 to 60 days following endovascular intervention may improve healing outcomes in select patients without uncontrolled infection.¹⁹

The optimal timing of minor amputation after lower limb revascularization remains uncertain. Available evidence suggests that delayed amputation may improve healing in select patients, but current data are limited by retrospective designs and heterogeneous population. Clinical decisions should therefore be individualized, balancing infection control, tissue viability, and perfusion recovery. Prospective multicenter studies are needed to establish evidence-based recommendations. 

© 2026 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Journal of Critical Limb Ischemia or HMP Global, their employees, and affiliates.